BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 23771014)

  • 21. Bilateral herpetic keratoconjunctivitis.
    Souza PM; Holland EJ; Huang AJ
    Ophthalmology; 2003 Mar; 110(3):493-6. PubMed ID: 12623810
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ocular findings in Japanese patients with varicella-zoster virus infection.
    Yoshida M; Hayasaka S; Yamada T; Yanagisawa S; Hayasaka Y; Nakamura N; Mihara M
    Ophthalmologica; 2005; 219(5):272-5. PubMed ID: 16123552
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incidence of herpes simplex virus keratitis in France.
    Labetoulle M; Auquier P; Conrad H; Crochard A; Daniloski M; Bouée S; El Hasnaoui A; Colin J
    Ophthalmology; 2005 May; 112(5):888-95. PubMed ID: 15878072
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factors associated with age of onset of herpes zoster ophthalmicus.
    Chan AY; Conrady CD; Ding K; Dvorak JD; Stone DU
    Cornea; 2015 May; 34(5):535-40. PubMed ID: 25710509
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effectiveness of the Recombinant Zoster Vaccine for Herpes Zoster Ophthalmicus in the United States.
    Lu A; Sun Y; Porco TC; Arnold BF; Acharya NR
    Ophthalmology; 2021 Dec; 128(12):1699-1707. PubMed ID: 33892049
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence in the prevention of the recurrence of herpes simplex and herpes zoster keratitis after eye surgery.
    Gessa-Sorroche M; Kanclerz P; Alio J
    Arch Soc Esp Oftalmol (Engl Ed); 2022 Mar; 97(3):149-160. PubMed ID: 35248396
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk of Herpes Zoster Ophthalmicus Recurrence After Recombinant Zoster Vaccination.
    Walia A; Sun Y; Acharya NR
    JAMA Ophthalmol; 2024 Mar; 142(3):249-256. PubMed ID: 38358762
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ocular manifestations in herpes zoster ophthalmicus.
    Puri LR; Shrestha GB; Shah DN; Chaudhary M; Thakur A
    Nepal J Ophthalmol; 2011; 3(2):165-71. PubMed ID: 21876592
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oral acyclovir for herpes simplex virus eye disease: effect on prevention of epithelial keratitis and stromal keratitis. Herpetic Eye Disease Study Group.
    Arch Ophthalmol; 2000 Aug; 118(8):1030-6. PubMed ID: 10922194
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Herpes zoster ophthalmicus natural history, risk factors, clinical presentation, and morbidity.
    Liesegang TJ
    Ophthalmology; 2008 Feb; 115(2 Suppl):S3-12. PubMed ID: 18243930
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early- and late-stage ocular complications of herpes zoster ophthalmicus in rural South Africa.
    Schaftenaar E; Meenken C; Baarsma GS; McIntyre JA; Verjans GM; Peters RP
    Trop Med Int Health; 2016 Mar; 21(3):334-9. PubMed ID: 26663773
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Herpes zoster ophthalmicus: the virus strikes back.
    Karlin JD
    Ann Ophthalmol; 1993 Jun; 25(6):208-15. PubMed ID: 8393312
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Corneal herpes simplex virus type 1 superinfection in patients with recrudescent herpetic keratitis.
    Remeijer L; Maertzdorf J; Buitenwerf J; Osterhaus AD; Verjans GM
    Invest Ophthalmol Vis Sci; 2002 Feb; 43(2):358-63. PubMed ID: 11818377
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epidemiology of Herpes Zoster Ophthalmicus: Recurrence and Chronicity.
    Tran KD; Falcone MM; Choi DS; Goldhardt R; Karp CL; Davis JL; Galor A
    Ophthalmology; 2016 Jul; 123(7):1469-75. PubMed ID: 27067924
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ocular herpes simplex: changing epidemiology, emerging disease patterns, and the potential of vaccine prevention and therapy.
    Pepose JS; Keadle TL; Morrison LA
    Am J Ophthalmol; 2006 Mar; 141(3):547-557. PubMed ID: 16490506
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incidence of Alpha-Herpes virus induced ocular disease in Suriname.
    Adhin MR; Grunberg MG; Labadie-Bracho M; Pawiroredjo J
    J Med Virol; 2012 Dec; 84(12):1937-42. PubMed ID: 23080500
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Herpes Zoster Ophthalmicus Clinical Presentation and Risk Factors for Loss of Vision.
    Niederer RL; Meyer JJ; Liu K; Danesh-Meyer HV
    Am J Ophthalmol; 2021 Jun; 226():83-89. PubMed ID: 33571476
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Herpes zoster ophthalmicus and HIV infection in Nigeria.
    Umeh RE
    Int J STD AIDS; 1998 Aug; 9(8):476-9. PubMed ID: 9702597
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acyclovir for the prevention of recurrent herpes simplex virus eye disease. Herpetic Eye Disease Study Group.
    N Engl J Med; 1998 Jul; 339(5):300-6. PubMed ID: 9696640
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Herpes Zoster Ophthalmicus: Presentation, Complications, Treatment, and Prevention.
    Litt J; Cunningham AL; Arnalich-Montiel F; Parikh R
    Infect Dis Ther; 2024 Jun; ():. PubMed ID: 38834857
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.